Host chromosomal DNA (DNA)

Host chromosomal DNA is the primary repository of genetic information in eukaryotic cells, organized into complex chromatin structures within the nucleus (National Human Genome Research Institute, 2023). It serves as the essential template for DNA replication, ensuring the faithful transmission of genetic material during cell division, and for transcription, which initiates the synthesis of proteins (Nature Education, 2014). In clinical pathology, damage to host chromosomal DNA or the presence of pathogenic mutations are central to the development of cancers and hereditary genetic diseases (NIH, 2022). Furthermore, the integration of viral genetic material into the host genome is a hallmark of persistent infections such as HIV-1 (StatPearls, 2023). Historically, DNA has been a major target for oncology treatments, where cytotoxic drugs like alkylating agents and intercalators disrupt DNA integrity to induce apoptosis in malignant cells (PubChem, 2024). Modern therapeutic approaches have expanded to include gene editing technologies, such as CRISPR-Cas9, which allow for the precise, site-specific modification of host chromosomal DNA to correct genetic disorders at their molecular source (Science, 2020).

Other names

Genomic DNANuclear DNADeoxyribonucleic acidChromatinHost genome

Therapeutic agents target host chromosomal DNA through several distinct mechanisms: alkylating agents (e.g., cyclophosphamide) form covalent bonds with DNA bases to create cross-links that inhibit replication; intercalating agents (e.g., doxorubicin) insert themselves between base pairs to disrupt the double helix structure; and topoisomerase inhibitors (e.g., etoposide) prevent the re-ligation of DNA strands during cellular processes (StatPearls, 2023; PubChem, 2024). Advanced gene therapies, such as CRISPR-Cas9, utilize programmable nucleases to induce site-specific double-strand breaks, enabling precise sequence insertion, deletion, or correction via cellular repair pathways (Nature, 2022).